Calix, Inc.

Historical Financial Statements

GAAP and Non-GAAP Statements of Operations 2021

($ in thousands)

GAAP

Non-GAAP

GAAP

Non-GAAP

GAAP

Non-GAAP

Qtr Ending

Qtr Ending

Qtr Ending

Qtr Ending

Ytd Ending

Ytd Ending

4/3/2021

4/3/2021

7/3/2021

7/3/2021

7/3/2021

7/3/2021

Revenue:

Systems

$

153,302

$

153,302

$

159,553

$

159,553

$

312,855

$

312,855

Services

8,772

8,772

9,117

9,117

17,889

17,889

Total revenue

162,074

162,074

168,670

168,670

330,744

330,744

Cost of revenue:

Systems (1) (6)

69,663

68,843

72,673

73,324

142,336

142,167

Services (2)

6,169

6,019

6,378

6,221

12,547

12,240

Total cost of revenue

75,832

74,862

79,051

79,545

154,883

154,407

Gross profit

86,242

87,212

89,619

89,125

175,861

176,337

Gross margin %

53.2%

53.8%

53.1%

52.8%

53.2%

53.3%

Sales and marketing (3)

28,051

26,604

29,710

27,987

57,761

54,591

Research and development (4)

24,364

22,781

25,716

24,072

50,080

46,853

General and administrative (5)

13,025

11,196

13,664

11,150

26,689

22,346

Total operating expenses

65,440

60,581

69,090

63,209

134,530

123,790

Income from operations

20,802

26,631

20,529

25,916

41,331

52,547

Interest expense, net

(125)

(125)

(119)

(119)

(244)

(244)

Other income, net

88

88

255

255

343

343

Total interest expense and other income, net

(37)

(37)

136

136

99

99

Provision for income taxes

150

150

207

207

357

357

Net income

$

20,615

$

26,444

$

20,458

$

25,845

$

41,073

$

52,289

Non-GAAP bridge to GAAP

(1) Cost of revenue -systems(stock-based compensation)

$

162

$

185

$

347

(2) Cost of revenue - services (stock-based compensation)

150

157

307

(3) Sales and marketing (stock-based compensation)

1,447

1,723

3,170

(4) Research and development (stock-based compensation)

1,583

1,644

3,227

(5) General and administrative (stock-based compensation)

1,829

2,514

4,343

(6) Intangible asset amortization

658

658

1,316

(7) U.S. tariff refund

-

(1,494)

(1,494)

Total non-GAAP expenses

$

5,829

$

5,387

$

11,216

GAAP net income

$

20,615

$

20,458

$

41,073

Calix's non-GAAP measures are not in accordance with, or an alternative for, GAAP and may be different from non-GAAP measures used by other companies. In addition, the above non-GAAP Consolidated Statements of Operations are not based on a comprehensive set of accounting rules or principles.

Calix, Inc.

Historical Financial Statements

Condensed Consolidated Balance Sheet 2021

($ in thousands)

4/3/2021

7/3/2021

Assets

Current assets:

Cash and cash equivalents

$

85,854

$

58,590

Marketable securities

64,174

117,259

Accounts receivable, net

74,408

80,164

Inventory

72,211

77,136

Prepaid expenses and other current assets

13,122

17,449

Total current assets

309,769

350,598

Property and equipment, net

20,103

19,663

Right-of-use operating leases

11,015

10,983

Goodwill

116,175

116,175

Other assets

11,073

10,416

Total assets

$

468,135

$

507,835

Liabilities and stockholders' equity

Current liabilities:

Accounts payable

$

29,224

$

34,971

Accrued liabilities

56,031

58,627

Deferred revenue

24,127

23,951

Total current liabilities

109,382

117,549

Long-term portion of deferred revenue

20,329

21,307

Operating leases

12,167

11,920

Other long-term liabilities

11,542

11,421

Stockholders' equity:

Common stock

1,572

1,580

Additional paid-in capital

961,846

972,259

Accumulated other comprehensive loss

(226)

(182)

Accumulated deficit

(648,477)

(628,019)

Total stockholders' equity

314,715

345,638

Total liabilities and stockholders' equity

$

468,135

$

507,835

Calix, Inc.

Historical Financial Statements

Condensed Consolidated Statement of Cash Flows 2021 ($ in thousands)

Qtr Ending

Qtr Ending

Ytd Ending

4/3/2021

7/3/2021

7/3/2021

Operating activities

Net income

$

20,615

$

20,458

$

41,073

Adjustments to reconcile net income to net cash provided by operating activities:

Stock-based compensation

5,171

6,223

11,394

Depreciation and amortization

4,077

3,660

7,737

Changes in operating assets and liabilities:

Accounts receivable, net

(4,989)

(5,756)

(10,745)

Inventory

(19,943)

(4,925)

(24,868)

Prepaid expenses and other assets

(1,321)

(5,069)

(6,390)

Accounts payable

16,156

5,762

21,918

Accrued liabilities

(12,856)

2,672

(10,184)

Deferred revenue

5,362

802

6,164

Other long-term liabilities

(2,374)

(368)

(2,742)

Net cash provided by operating activities

9,898

23,459

33,357

Investing activities:

Purchases of property and equipment

(2,274)

(1,654)

(3,928)

Purchases of marketable securities

(54,192)

(93,085)

(147,277)

Maturities of marketable securities

43,000

40,000

83,000

Net cash used in investing activities

(13,466)

(54,739)

(68,205)

Financing activities

Proceeds from common stock issuances related to employee benefit plans

8,639

4,198

12,837

Payments related to financing arrangements

-

(212)

(212)

Net cash provided by financing activities

8,639

3,986

12,625

Effect of exchange rate changes on cash and cash equivalents

(24)

30

6

Net increase (decrease) in cash and cash equivalents

5,047

(27,264)

(22,217)

Cash and cash equivalents at beginning of period

80,807

85,854

80,807

Cash and cash equivalents at end of period

$

85,854

$

58,590

$

58,590

Attachments

  • Original document
  • Permalink

Disclaimer

Calix Inc. published this content on 26 July 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 26 July 2021 21:09:07 UTC.